HEATHER DUFOUR: Open Payments
NPI 1063838811 · DARTMOUTH, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$427 in 13 payments from 8 companies in 2025. Trend: 2023 $98 · 2024 $375 · 2025 $427
Food & beverage: $427
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 1 | $128 |
| Ardelyx, Inc. | 3 | $83 |
| Regeneron Healthcare Solutions, Inc. | 3 | $76 |
| GENZYME CORPORATION | 2 | $55 |
| Madrigal Pharmaceuticals | 1 | $29 |
| Phathom Pharmaceuticals, Inc. | 1 | $25 |
| ABBVIE INC. | 1 | $16 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $15 |
Products named: DUPIXENT, TREMFYA, IBSRELA, REZDIFFRA, VOQUEZNA, SKYRIZI, RELISTOR.
Industry payments across MA — which companies pay providers there.
